- Kinaxo Biotechnologies Am Klopferspitz 19a Martinsried 82152 Germany
Kinaxo Biotechnologies has announced that it has entered a second collaboration with Takeda Pharmaceutical Company, Osaka, Japan.
Kinaxo Biotechnologies will apply its Phosphoscout phosphoproteomics technology to support targeted treatment approaches currently under development at Roche Diagnostics in Penzberg, Germany.
21 October 2009 - Kinaxo Biotechnologies has entered into a collaboration with Roche Diagnostics in the field of phosphoproteomics.
Kinaxo Biotechnologies has applied its Cellular Target Profiling technology to identify the protein kinase Mtor as a new cellular target of celecoxib (Celebrex, Pfizer).
Kinaxo Biotechnologies has announced that it has entered into a two-year collaboration with Boehringer Ingelheim.